Related references
Note: Only part of the references are listed.Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials
Robson Zazula et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2021)
Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
Maria Antonietta Nettis et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls
Emanuele F. Osimo et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Minocycline for Depressive Symptoms: a Meta-Analysis of Randomized, Double-Blinded, Placebo-Controlled Trials
Dong-Bin Cai et al.
PSYCHIATRIC QUARTERLY (2020)
Immunoneuropsychiatry - novel perspectives on brain disorders
Katrin Pape et al.
NATURE REVIEWS NEUROLOGY (2019)
Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial
Roger S. McIntyre et al.
JAMA PSYCHIATRY (2019)
Biomarker-Guided Anti-inflammatory Therapies: From Promise to Reality Check
Michael Berk et al.
JAMA PSYCHIATRY (2019)
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Hubertus Himmerich et al.
FRONTIERS IN PSYCHIATRY (2019)
Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials
Joshua D. Rosenblat et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis
Magdalena Wiedlocha et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial
Muhammad Husain et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Oxidative stress, inflammation and treatment response in major depression
Daniel Lindqvist et al.
PSYCHONEUROENDOCRINOLOGY (2017)
Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor
Kyoko Hasebe et al.
ACTA NEUROPSYCHIATRICA (2017)
Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial
Olivia M. Dean et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies
C. A. Kohler et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety- and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice
Jafar Majidi et al.
BRAIN RESEARCH BULLETIN (2016)
Critical Data-Based Re-Evaluation of Minocycline as a Putative Specific Microglia Inhibitor
Thomas Moller et al.
GLIA (2016)
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
G. B. Rogers et al.
MOLECULAR PSYCHIATRY (2016)
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Immune mechanisms linked to depression via oxidative stress and neuroprogression
Nataliia Bakunina et al.
IMMUNOLOGY (2015)
Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial
Muhammad I. Husain et al.
TRIALS (2015)
Minocycline: far beyond an antibiotic
N. Garrido-Mesa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Determinants of Serum Concentrations of Lipopolysaccharide-Binding Protein (LBP) in the Adult Population: The Role of Obesity
Arturo Gonzalez-Quintela et al.
PLOS ONE (2013)
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
Seyed-Hesameddin Abbasi et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Does minocycline have antidepressant effect?
Chi-Un Pae et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia
Christopher J. Henry et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Mediators and moderators of treatment effects in randomized clinical trials
HC Kraemer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Share Paper
